Synthesis of long-chain polyunsaturated fatty acids by recombinant cell

Patent metadata

Field	Value
Publication number	US-9458410-B2
Application number	US-201414503002-A
Country	US
Kind code	B2
Filing date	Sep 30, 2014
Priority date	Apr 22, 2004
Publication date	Oct 4, 2016
Grant date	Oct 4, 2016

Abstract

The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desaturase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids.

First claim

The invention claimed is:

1. A process for producing eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, comprising the steps of (i) growing a transgenic oilseed plant which comprises eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid in an esterified form as part of triglycerides in its seed, wherein the total fatty acid of the seed comprises at least 2.5% ω3 C20 fatty acids (w/w) and wherein the docosapentaenoic acid is present at a level based on a conversion ratio of eicosapentaenoic acid to docosapentaenoic acid of at least 5% (w/w), and (ii) harvesting the seed from the transgenic plant.

2. The process of claim 1 , wherein the total fatty acid of the seed comprises at least 1.5% eicosapentaenoic acid and at least 0.13% docosapentaenoic acid (w/w).

3. The process of claim 1 , wherein the total fatty acid of the seed comprises at least 2.1% eicosapentaenoic acid and less than 0.1% eicosatrienoic acid (w/w).

4. The process of claim 1 , wherein at least 50% (w/w) of the eicosapentaenoic acid and docosapentaenoic acid of the seed is incorporated into triacylglycerols in the seed.

5. The process of claim 1 , wherein oil in the seed comprises at least 50% triacylglycerols.

6. The process of claim 1 , wherein the total fatty acid of the seed comprises at least 7.9% C20 fatty acids (w/w).

7. The process of claim 6 , wherein the total fatty acid of the seed comprises at least 10.2% C20 fatty acids (w/w).

8. The process of claim 7 , wherein the total fatty acid of the seed comprises at least 1.5% eicosapentaenoic acid and at least 0.13% docosapentaenoic acid (w/w).

9. The process of claim 7 , wherein at least 50% (w/w) of the eicosapentaenoic acid and docosapentaenoic acid of the seed is incorporated into triacylglycerols in the seed.

10. The process of claim 1 , wherein the docosapentaenoic acid is present at a level based on a conversion ratio of eicosapentaenoic acid to docosapentaenoic acid of at least 7% (w/w).

11. The process of claim 10 , wherein the total fatty acid of the seed comprises at least 1.5% eicosapentaenoic acid and at least 0.13% docosapentaenoic acid (w/w).

12. The process of claim 10 , wherein at least 50% (w/w) of the eicosapentaenoic acid and docosapentaenoic acid of the seed is incorporated into triacylglycerols in the seed.

13. The process of claim 10 , wherein the docosapentaenoic acid is present at a level based on a conversion ratio of eicosapentaenoic acid to docosapentaenoic acid of at least 10% (w/w).

14. The process of claim 13 , wherein the total fatty acid of the seed comprises at least 1.5% eicosapentaenoic acid and at least 0.13% docosapentaenoic acid (w/w).

15. The process of claim 13 , wherein at least 506 (w/w) of the eicosapentaenoic acid and docosapentaenoic acid of the seed is incorporated into triacylglycerols in the seed.

16. The process of claim 1 , wherein the oilseed plant is a Brassica plant.

17. The process of claim 10 , wherein the oilseed plant is a Brassica plant.

18. The process of claim 13 , wherein the oilseed plant is a Brassica plant.

19. The process of claim 17 , wherein the Brassica plant is a canola plant.

20. The process of claim 18 , wherein the Brassica plant is a canola plant.

Assignees

• Commw Scient Ind Res Org

Inventors

• Singh Surinder Pal
• Robert Stanley Suresh
• Nichols Peter David
• Blackburn Susan Irene Ellis
• Zhou Xue-Rong
• Petrie James Robertson
• Green Allan Graham

Classifications

• A61P9/10

  for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

• A61P3/10

  for hyperglycaemia, e.g. antidiabetics · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P9/14

  Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers · CPC title

• A61P9/12

  Antihypertensives · CPC title